Ligand Pharmaceuticals (LGND)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

116.91

-0.05%

After-hours Dec 13, 2024, 04:00 PM EST

Ligand Pharmaceuticals Forcast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for LGND stock have an median target of 143, with a low estimate of 135 and a high estimate of 150. The median target predicts an increase of 22.25% from the current stock price of 116.97.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$135	$143	$143	$150
Change	15.41%	22.25%	22.25%	28.24%

AI Analyst Report

RBC Capital has reaffirmed its Outperform rating f... Unlock content with Pro Subscription

Updated Dec 11, 2024

Rating	Jun 24	Jul 24	Aug 24	Oct 24	Nov 24	Dec 24
Strong Buy	0	1	1	1	1	0
Buy	2	2	3	3	4	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	3	4	4	5	2

Financial Forecast this Year

Revenue This Year

156.29M

from 131.31M

19.0%

from 131.31M

Revenue Next Year

180.90M

from 156.29M

15.8%

from 156.29M

EPS This Year

5.37

from 3.02

77.8%

from 3.02

EPS Next Year

3.8

from 5.37

-29.2%

from 5.37